Patriot Financial Group Insurance Agency LLC Grows Position in SPDR S&P Biotech ETF $XBI

Patriot Financial Group Insurance Agency LLC raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 118.8% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 16,322 shares of the exchange traded fund’s stock after purchasing an additional 8,861 shares during the period. Patriot Financial Group Insurance Agency LLC’s holdings in SPDR S&P Biotech ETF were worth $2,085,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Morgan Stanley raised its stake in shares of SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after buying an additional 882,718 shares during the period. Wells Fargo & Company MN lifted its position in shares of SPDR S&P Biotech ETF by 75.7% during the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after buying an additional 1,536,122 shares in the last quarter. Avoro Capital Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $256,053,000. Bessemer Group Inc. grew its stake in shares of SPDR S&P Biotech ETF by 13.5% during the 4th quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock valued at $225,965,000 after acquiring an additional 220,244 shares during the period. Finally, Ameriprise Financial Inc. increased its holdings in SPDR S&P Biotech ETF by 40.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock worth $122,906,000 after acquiring an additional 353,351 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $155.38 on Monday. SPDR S&P Biotech ETF has a 12 month low of $82.04 and a 12 month high of $155.93. The stock has a market cap of $9.91 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The company’s 50 day moving average is $135.24 and its two-hundred day moving average is $128.73.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.